Afficher la notice abrégée

dc.contributor.authorSaavedra‑Mitjans, M.
dc.contributor.authorFerrand1 · Noe Garin, E.
dc.contributor.authorJean‑François Bussières, J. F.
dc.contributor.authorRodríguez-Murphy, E. (Trad)
dc.date.accessioned2026-07-22T09:56:32Z
dc.date.available2026-07-22T09:56:32Z
dc.date.issued2018
dc.identifier.citationSaavedra-Mitjans, M., Ferrand, É., Garin, N. et al. Role and impact of pharmacists in Spain: a scoping review. Int J Clin Pharm 40, 1430–1442 (2018). https://doi.org/10.1007/s11096-018-0740-7es_ES
dc.identifier.issn2210-7703
dc.identifier.urihttp://hdl.handle.net/10366/172254
dc.description.abstractBackground The role of the pharmacist has evolved greatly over the last decades, expanding to patient-oriented activities, administrative tasks and public health functions. However, considerable differences emerge across regions. Aim of the review To gather evidence in order to describe and highlight the different characteristics of the pharmacists’ role and the impact of their activities in Spain. Method A review of the existing literature was conducted. The literature search was undertaken in PubMed between 01/01/2006 and 15/08/2017. Results were screened and reviewed to extract previously established criteria such as author(s), publication year, language, study design, setting, pharmaceutical activity, patient care programs, targeted diseases and intervention description using DEPICT2 tool. Pharmaceutical intervention were classified into eight outcome measures and categorized by types of outcomes reported: descriptive or impact evaluation regarding the effect of the service (positive, neutral or negative). Results The search strategy resulted in 473 articles and 108 articles met the inclusion criteria. The most common design was observational (n = 76, 70%). Most articles were published after 2011 (75%), in English (69%). Studies were conducted in hospitals (60%) and community pharmacies (30%). Of the 24 pharmaceutical activities identified, medication review was the activity most frequently studied (n = 42), followed by patient education (n = 29), risk and prevention (n = 27) and medication reconciliation (n = 19). Only 39 articles (36%) had outcome measures with impact evaluation. Of the 223 impact outcome measures, 48% (107/223) had a positive effect. Conclusion This review shows the substantial scientific production focusing on pharmacy practice in Spain over the last years. The evidence reviewed reflects the pharmacist role at various professional settings, providing a wide variety of activities on diverse targeted diseases and patient care programs, in line with the increasing specialization of clinical pharmacists over the last years.es_ES
dc.format.mimetypeapplication/pdf
dc.language.isoenges_ES
dc.publisherSpringeres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationales_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/es_ES
dc.subjectClinical pharmacyes_ES
dc.subjectCommunity pharmacyes_ES
dc.subjectHospital pharmacyes_ES
dc.subjectPharmacy practicees_ES
dc.subjectPrimary care pharmacyes_ES
dc.titleRole and impact of pharmacists in Spain: a scoping reviewes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.journal.titleInternational Journal of Clinical Pharmacyes_ES
dc.issue.number40es_ES
dc.page.initial1430es_ES
dc.page.final1442es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 International
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 International